MedTrace Logo

Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults

NCT04362943 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 576

Last updated 2021-07-28

No results posted yet for this study

Summary

Retrospective clinical-epidemiological study aimed at characterizing COVID-19 disease in adults older than 70 years, hospitalized in the "Perpetuo Socorro" Hospital of Albacete (Spain) from 09/03/2020 until 20/04/2020. Secondary objectives will be to analyze clinical-epidemiological characteristics of COVID-19 patients treated with Baricitinib or Anakinra, and to describe the efficacy and secondary effects of those drugs.

Conditions

Interventions

DRUG

Baricitinib or Anakinra

Treatment with either Baricitinib or Anakinra during hospitalization, in real world, and under usual clinical care.

Sponsors & Collaborators

  • Complejo Hospitalario Universitario de Albacete

    lead OTHER

Principal Investigators

  • Pedro Abizanda Soler, MD,PhD · Head Geriatrics Department

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-20
Primary Completion
2021-04-15
Completion
2021-04-15
FDA Drug
Yes

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04362943 on ClinicalTrials.gov